About Hany Michail
Form D filings for Hanimune Therapeutics in 2023 list Hany Michail as director.
Hany Michail first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Hany Michail in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Hany Michail works with at each company, as listed on that company's latest Form D.
Hanimune Therapeutics Inc · Form D, Feb 7, 2023
ML
Meenal Lele
Chief Executive Officer and director